Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec:13:6-11.
doi: 10.1016/j.ijcme.2016.08.002. Epub 2016 Aug 28.

Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis

Michelle J Ormseth  1 , Patricia G Yancey  1 , Suguru Yamamoto  1 , Annette M Oeser  1 , Tebeb Gebretsadik  1 , Ayumi Shintani  1 , MacRae F Linton  1 , Sergio Fazio  2 , Sean S Davies  1 , L Jackson Roberts 2nd  1 , Kasey C Vickers  1 , Paolo Raggi  3 , Valentina Kon  1 , C Michael Stein  1
Affiliations

Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis

Michelle J Ormseth et al. IJC Metab Endocr. 2016 Dec.

Abstract

Background/objectives: Cardiovascular (CV) risk is increased in patients with rheumatoid arthritis (RA), but not fully explained by traditional risk factors such as LDL and HDL cholesterol concentrations. The cholesterol efflux capacity of HDL may be a better CV risk predictor than HDL concentrations. We hypothesized that HDL's cholesterol efflux capacity is impaired and inversely associated with coronary atherosclerosis in patients with RA.

Methods: We measured the net cholesterol efflux capacity of apolipoprotein B depleted serum and coronary artery calcium score in 134 patients with RA and 76 control subjects, frequency-matched for age, race and sex. The relationship between net cholesterol efflux capacity and coronary artery calcium score and other clinical variables of interest was assessed in patients with RA.

Results: Net cholesterol efflux capacity was similar among RA (median [IQR]: 34% removal [28, 41%]) and control subjects (35% removal [27%, 39%]) (P=0.73). In RA, increasing net cholesterol efflux capacity was not significantly associated with decreased coronary calcium score (OR=0.78 (95% CI 0.51-1.19), P=0.24, adjusted for age, race and sex, Framingham risk score and presence of diabetes). Net cholesterol efflux capacity was not significantly associated with RA disease activity score, C-reactive protein, urinary F2-isoprostanes, or degree of insulin resistance in RA.

Conclusions: Net cholesterol efflux capacity is not significantly altered in patients with relatively well-controlled RA nor is it significantly associated with coronary artery calcium score.

Keywords: HDL; athero; cholesterol efflux; lipoprotein; rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors report no relationships that could be construed as a conflict of interest.

Figures

Fig. 1
Fig. 1. Net cholesterol efflux capacity of HDL enriched serum in patients with RA and control subjects
Net cholesterol efflux of HDL enriched serum was measured in 134 patients with RA and 76 control subjects. In RA, the median [IQR] net cholesterol efflux capacity was 34% [28%, 41%], which was similar to controls (35% [27%, 39%], P=0.73).
See this image and copyright information in PMC

References

    1. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994 Apr;37(4):481–494. - PubMed
    1. Pincus T, Sokka T, Wolfe F. Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthritis Rheum. 2001 Jun;44(6):1234–1236. - PubMed
    1. Chung CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005 Oct;52(10):3045–3053. - PubMed
    1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. - PubMed
    1. Chung CP, Oeser A, Raggi P, Sokka T, Pincus T, Solus JF, et al. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheum. 2010 Aug;37(8):1633–1638. - PMC - PubMed

LinkOut - more resources